Emerging and re-emerging viruses

Emerging and re-emerging viruses

Closed
МООК
en
Английский
24 h
This content is rated 0 out of 5
Source
  • From www.fun-mooc.fr
Conditions
  • Free Access
  • Бесплатный сертификат
More info
  • 8 Sequences
  • Advanced Level
  • Starts on 14 февраля 2022
  • Ends on 8 апреля 2022

Their employees are learning daily with Edflex

  • Safran
  • Air France
  • TotalEnergies
  • Generali
Learn more

Course details

Syllabus

Chapter 1 – Introduction

  • W1-1: General Introduction
  • W1-2: Definition: Emerging and re-emerging
  • W1-3 : Principles : Vectors, Hosts, Reservoirs…
  • W1-4: One Health (Hervé Bourhy, Institut Pasteur)

Chapter 2 – Molecular mechanisms that drive viruses to be emerging or re-emerging

  • W2-1 : Newly identified viruses (Marc Eloit, Institut Pasteur)
  • W2-2 : Avian Influenza (Jean-Claude Manuguerra, Institut Pasteur)
  • W2-3: Previously known viruses that acquired additional virulence traits: Influenza viruses 1 and 2 (Sylvie van der Werf, Institut Pasteur)
  • W2-4: Control of the host on the virus (Carla Saleh, Institut Pasteur)

Chapter 3 – Conditions that favor emergence or re-emergence of viruses

  • W3-1: Changes in urbanization, human behavior (Pascal Handschumacher UNISTRA)
  • W3-2: Changes in Climate, deforestation, Natural disasters(Joacim Rocklöv (Université d’Umea, Sweden)
  • W3-3 : Coronavirus : SARS, MERS-CoV (Luis Enjuanes, Madrid)
  • W3-4: Yellow Fever(Nolween Jouvenet, Institut Pasteur)
  • W3-5: Hantavirus and Lassa Fever (Noel Tordo, Institut Pasteur)
  • W3-6: Human-nonhuman primate contact as a driver of viral emergence (Tamara Gilles-Vernick)
  • W3-7: A 20 year experience of Bluetongue circulation in Europe (Damien Vitour)

Chapter 4 – One health

  • W4-1: Bornavirus diseases (Hilde Angermeier, Institut Pasteur EUPHEM)
  • W4-2: Nipah Virus (Birgit Nikolai)
  • W4-3: Dengue (Marie Flamand, Institut Pasteur)
  • W4-4: Rift valley fever (Benjamin Brennan, Glascow)
  • W4-5: Crimean-Congo virus (Claudia Filippone, Institut Pasteur Madagascar)
  • W4-6: Hepatitis E (Nicole Pavio, ANSES Maisons-Alfort)

Chapter 5 : Epidemiology and Modelling

  • W5-1: Phylogeny and viruses (Noël Tordo, Institut Pasteur)
  • W5-2: Epidemiology of Zika (Arnaud Fontanet, Institut Pasteur)
  • W5-3: Epidemiology of Hepatitis C in Egypt (Arnaud Fontanet, Institut Pasteur)
  • W5-4: Ebola virus outbreak: From the field to the lab (Christophe Peyrefitte, Institut Pasteur Dakar)
  • W5-5: Quasispecies and viruses (Esteban Domingo, Madrid)
  • W5-6: Modelling the epidemiology of viral infection (Simon Cauchemez, Institut Pasteur)

Chapter 6 : Detection, Early management and infection control

  • W6-1 : Surveillance of vectors (Norbert Becker, Heidelberg)
  • W6-2 : Surveillance of viral diseases (Harold Noël, Santé Publique France)
  • W6-3 : Molecular epidemiology (Antoine Gessain, Institut Pasteur)
  • W6-4 : CIBU and Arboviruses (Jessica Vanhomwegen, Institut Pasteur)

Chapter 7 : Prevention and response

  • W7-1: Vector control activities (Norbert Becker, Heidelberg)
  • W7-2: Bioterrorism lessons from the past and Orthopoxvirus Antiviral strategy approach (Christophe Peyrefitte, Institut Pasteur Dakar)
  • W7-3: Preparedness (Marie-Paule Kieny, Inserm)
  • W7-4: Example: OITF of IP (Eileen Farnon/Amber Kunkel/Jean-Claude Manuguerra)
  • W7-5: Public health response: from science to politics (Didier Houssin, DGS)
  • W7-6: Vaccines (Frédéric Tangy, Institut Pasteur)
  • W7-7: Therapeutics (Etienne Decroly, AFMB Polytech, Luminy)
  • W7-8: WHO list of blueprint priority diseases (Marie-Paule Kieny, WHO)

Chapter 8 : Focus on SRAS-CoV2 - CoVid19

  • W8-1 : Covid19 - Virology (Olivier Schwartz)
  • W8-2 : Covid19 - Epidemiology (Arnaud Fontanet)
  • W8-3 : Covid19 - Vaccinology (Christiane Gerke)
  • W8-4 : Covid19 - Structure and Monoantibodies Therapy (Felix Rey)
  • W8-5 : Covid19 - Covid19 and its impact on the CNS (Hervé Bouhry ou/et Guilherme Dias De Melo)

 

 

Prerequisite

We recommend a good scientific background (such as a bachelor of life science)./ Un bon niveau scientifique est recommandé pour suivre ce MOOC (licence en sciences de la vie).

Instructors

Jean-Pierre Vartanian
Jean-Pierre Vartanian is Associate Professor at Institut Pasteur (Molecular Retrovirology Unit). He is the co-director of the Fundamental Virology course at the Institut Pasteur. His work is focused on identifying restriction factors involved in viral replication and the role of cellular RNA/DNA editing enzymes with antiviral activity against a range of human pathogens.

Pierre-Emmanuel Ceccaldi
Pierre-Emmanuel Ceccaldi is Professor at Université de Paris and Team Leader in the Epidemiology and Pathophysiology of Oncogenic Viruses Unit, Institut Pasteur. He is the co-director of the Fundamental Virology course at the Institut Pasteur. His work is focused on the interactions of different viruses with host barriers (blood-brain barrier, intestinal barrier…), and neuromuscular system.

Hilde Angermeier
Hilde Angermeier is a microbiologist and post-doctoral fellow within the European Public Health Microbiology training program (EUPHEM) of the European Centre for Disease Prevention and Control (ECDC). She is based for these two years at Institut Pasteur in Paris, France, where she is involved in different surveillance, public health microbiology research, laboratory and outbreak investigation, biorisk and quality management as well as teaching projects. Her ongoing projects involve the characterization of novel Yersinia species, seroprevalence studies on Hantaviruses and Leptospira, the genomic investigation of a recurrent Salmonella outbreak in France as well as the evaluation of the performance of rabies diagnostic tests in the frame of the quality management system present in the National Reference Center (NRC) for rabies. In addition, she has been involved in teaching during a workshop on rabies diagnostic techniques in Zimbabwe and in the development of massive open-online courses (MOOCs) of the Institut Pasteur.

Editor

L'Institut Pasteur est une fondation française privée à but non lucratif, sise à Paris, qui se consacre à l'étude de la biologie, des micro-organismes, des maladies et des vaccins.

Créé en 1888 grâce à une souscription publique internationale, il est ainsi nommé d'après Louis Pasteur1, son fondateur et premier directeur qui, en 1885, a mis au point le premier vaccin contre la rage.

Depuis plus d’un siècle, l’Institut Pasteur est à la pointe de la lutte contre les maladies infectieuses. Cette organisation internationale de recherche a été la première à isoler en 1983 le virus de l'immunodéficience humaine (VIH), virus qui provoque le syndrome d'immunodéficience acquise (SIDA). Au fil des années, il a été à l'origine de découvertes révolutionnaires qui ont permis à la médecine de contrôler des maladies virulentes, telles que la diphtérie, le tétanos, la tuberculose, la poliomyélite, la grippe, la fièvre jaune, la peste épidémique, l'hépatite B, le SIDA.

Platform

France Université Numérique est le diffuseur des cours en ligne des établissements d’enseignement supérieur français et de leurs partenaires.

Il opère plusieurs plateformes de diffusion, dont la plus connue, FUN MOOC, est la première plateforme académique francophone mondiale. Grâce à de nombreux établissements partenaires, cette plateforme propose un vaste catalogue de cours s’enrichissant de jour en jour avec des thématiques variées et d’actualité.
 

Get certified in

‌
This content is rated 4.5 out of 5
(no review)
This content is rated 4.5 out of 5
(no review)
Complete this resource to write a review